基于特戈普拉桑的10天并发治疗作为Helicobacter pylori根除的第一线治疗
Yong Hwan Kwon1,2, Seong Woo Jeon1,2, Su Youn Nam2
1Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
基于泰戈普拉桑的四重疗法有效地消灭了Helicobacter pylori. 这种10天的疗法显示出高的成功率,即使抗生素耐药性,提供了一个有前途的治疗选择.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 杆菌感染是全球重要的健康问题.
- 有效的根除疗法对于预防相关并发症至关重要.
- 需要新的治疗策略来克服抗生素耐药性.
研究的目的:
- 评估基于泰戈普拉桑的,不含比斯木斯的四重疗法对初级H. pylori根除的疗效.
- 评估这一方案作为一线治疗的成功率.
- 为了确定治疗是否有效,尽管存在抗生素耐药性模式.
主要方法:
- 进行了一项前性,单臂,单中心研究.
- 84名参与者接受了为期10天的基于泰戈普拉桑的并发治疗 (泰戈普拉桑,阿莫西西林,克拉里思罗米辛,美特罗尼达).
- 进行了抗生素敏感性测试,并分析了根除率.
主要成果:
- 总体意图治疗的根除率为90.5%,每个方案的根除率为96.2%.
- 尽管一些参与者 (分别为26.0%和42.5%) 存在显著的克拉里素和甲尼醇耐药性,但66.1%的参与者成功消除了这种疾病.
- 84名参与者中有79人 (94.0%) 完成了第一线治疗.
结论:
- 基于特戈普拉桑的10天并发治疗显示出相当大的疗效,作为H. pylori根除的第一线治疗.
- 这种方案为H. pylori治疗提供了一个可行的选择,即使存在抗生素耐药性.
- 进一步的研究可能会探索它在不同患者群体和耐药性概况中的作用.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
